For patients with obesity and atrial fibrillation (Afib), GLP-1 receptor agonist drugs may be the weight loss approach that better addresses their arrhythmia, observational data suggested.

Share on Pinterest Untreated AFib is associated with a 45% increased risk of developing mild cognitive impairment, a new research letter says. spxChrome/Getty Images For people with untreated atrial ...

An analysis of two large cohort studies finds that carriers of disease-causing variants within genes for three ...

NORTH CHARLESTON, S.C. (WCSC) - Doctors at Trident Medical Center in conjunction with a group at Mount Sinai in New York have begun a new trial already showing promising results in treating atrial ...

Today we are discussing a common but treatable cardiac condition called Atrial Fibrillation, also known as AFIB. And joining us today Dr. Shen , Cardiologist at MercyOne Genesis. I toured the White ...

PANAMA CITY, Fla. (WJHG/WECP) - The month of September calls for attention to atrial fibrillation. Although Afib is one of the most commonly occurring heart rhythm disorders, it can be difficult to ...

Apple's atrial fibrillation (AFib) history feature on Apple Watch has been qualified by the FDA under its Medical Device Development Tools (MDDT) program, the first digital health technology feature ...

(WNDU) - Atrial fibrillation, or AFib, is the most common type of heart arrhythmia. It’s estimated 12 million people in the U.S. are living with it. If not treated, it can lead to blood clots and ...

Another benefit of GLP-1 receptor agonist (RA) use may be protection from persistent atrial fibrillation (Afib or AF) after ablation, according to a large Veterans Affairs database. New initiators of ...

Share on Pinterest A new study found that ablation is an effective treatment for AFib in most patients. VICTOR TORRES/Stocksy A recent study investigates how well radiofrequency-based ablation treats ...